Genertec Universal Medical subsidiary secures approval for new renewable corporate bonds

China Universal Leasing Co., Ltd., a wholly-owned subsidiary of Genertec Universal Medical Group Company Limited, has received approval from the China Securities Regulatory Commission (CSRC) to issue renewable corporate bonds. This third tranche of bonds, designated as "2025 Renewable Corporate Bonds (Tranche 3)," will have an aggregate principal amount of up to RMB300 million. The total approved issuance to qualified investors in the PRC is RMB2 billion, with RMB650 million already issued.

The bonds will have a basic term of one year, with a repricing period matching the basic term. The issuer retains the option to extend the term or repay the bonds at the end of each period. The interest rate for the first term will be fixed through a book-building process, while subsequent terms will adjust based on a benchmark rate, initial interest rate spread, and 300 basis points.

The proceeds from this issuance will serve as supplementary operating funds for China Universal Leasing. The bonds are expected to be issued off-line from October 24, 2025, through price enquiring and placing, with an AAA credit rating for the issuer as assessed by China Lianhe Credit Rating Co., Ltd. on October 16, 2025.